Dilsaver Evelyn S 4

What Happened
Evelyn S. Dilsaver, a director of QuidelOrtho Corporation (QDEL), received 6,829 shares on May 29, 2026 when previously granted restricted stock units vested and were converted into common stock. The Form 4 reports an award/acquisition (code A) of 6,829 shares at $0.00 and a simultaneous conversion/exercise of a derivative (code M) of 6,829 units at $0.00 — i.e., no cash purchase or sale occurred. This was a vesting/award event (compensation) rather than an open-market trade.

Key Details

• Transaction date: May 29, 2026.
• Reported on Form 4 filed June 2, 2026 (timely filing).
• Items reported: A (award/acquisition) — 6,829 shares @ $0.00; M (exercise/conversion of derivative) — 6,829 units @ $0.00.
• Footnotes: F1 — release of RSUs previously reported; F2 — each RSU = right to one share; F3 — RSUs vested on May 29, 2026.
• Shares owned after the transaction: not specified in the provided filing details.

Context
This was a routine equity compensation event (RSU vesting and conversion to common shares) for a director — not a purchase or sale that signals immediate bullish or bearish action. The filing shows no immediate sale of the shares and no cashless exercise or tax-withholding detail was provided in the supplied excerpt.